Law360, New York (November 20, 2008, 12:00 AM ET) -- Hoffmann-La Roche has vowed to appeal after three plaintiffs who claimed they developed inflammatory bowel disease after taking the acne drug Accutane were awarded almost $13 million by a New Jersey jury Wednesday afternoon.
The verdict followed a five-week trial in New Jersey Superior Court in Atlantic City. There were three separate cases, but they were tried as one. The defendants were Hoffmann-La Roche and Roche Laboratories Inc.
With respect to each individual plaintiff, the jury voted 7-1 that Roche failed to provide an adequate warning...
Roche Vows To Appeal $12.9M Accutane Verdict
To view the full article, take a free trial now.
